Top

European Journal of Nuclear Medicine and Molecular Imaging

Published in:

01-05-2017 | Editorial Commentary

Less is more: reconsidering the need for regular use of diagnostic whole body radioiodine scintigraphy in the follow-up of differentiated thyroid cancer

Authors: Christian Pirich, Gregor Schweighofer-Zwink

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 5/2017

Excerpt

By far, differentiated thyroid cancer (DTC) is the most common form of thyroid cancer (TC) accounting for about 90% of all TC in most industrialized countries [1]. Incidence has increased throughout the world during recent decades and is mostly attributed to an increase of very small (<10 mm in maximum diameter) to small tumors [1, 2]. The widespread use of imaging technologies, namely ultrasound for the work-up of nodular thyroid disease and TC screening have been identified as probable causes of this epidemiological trend [3]. …

Kithara CM, Sosa JA. The changing incidence of thyroid cancer. Nat Rev Endocrinol. 2016;12:646–53.CrossRef

Morris LG, Tuttle RM, Davies L. Changing trends in the incidence of thyroid cancer in the United States. JAMA Otolaryngol Head Neck Surg. 2016;142:709–11.CrossRefPubMedPubMedCentral

Kent WD, Hall SF, Isotalo PA, et al. Increased incidence of differentiated thyroid carcinoma and detection of subclinical disease. CMAJ. 2007;177:1357–61.CrossRefPubMedPubMedCentral

Lundgren CI, Hall P, Ekbom A, Frisell J, Zedenius J, Dickman PW. Incidence and survival of Swedish patients with differentiated thyroid cancer. Int J Cancer. 2003;106:569–73.CrossRefPubMed

Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26:1–133.CrossRefPubMedPubMedCentral

Sosa JA, Hanna JW, Robinson KA, Lanman RB. Increases in thyroid nodule fine-needle aspirations, operations, and diagnoses of thyroid cancer in the United States. Surgery. 2013;154:1420–6.CrossRefPubMed

Dralle H, Musholt TJ, Schabram J, et al. German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors. Langenbeck’s Arch Surg. 2013;398:347–75.CrossRef

Mazzaferri EL, Kloos RT. Is diagnostic iodine-131 scanning with recombinant human TSH useful in the follow-up of differentiated thyroid cancer after thyroid ablation? J Clin Endocrinol Metab. 2002;87:1490–8.CrossRefPubMed

Pacini F, Capezzone M, Elisei R, et al. Diagnostic 131-iodine whole-body scan may be avoided in thyroid cancer patients who have undetectable stimulated serum Tg levels after initial treatment. J Clin Endocrinol Metab. 2002;87:1499–501.CrossRefPubMed

10.

Kohlfuerst S, Igerc I, Lobnig M, et al. Posttherapeutic (131)I SPECT-CT offers high diagnostic accuracy when the findings on conventional planar imaging are inconclusive and allows a tailored patient treatment regimen. Eur J Nucl Med Mol Imaging. 2009;36:886–93.CrossRefPubMed

11.

Xue YL, Qiu ZL, Song HJ, Luo QY. Value of ¹³¹I SPECT/CT for the evaluation of differentiated thyroid cancer: a systematic review of the literature. Eur J Nucl Med Mol Imaging. 2013;40:768–878.CrossRefPubMed

12.

Perros P, Boelaert K, Colley S, British Thyroid Association, et al. Guidelines for the management of thyroid cancer. Clin Endocrinol. 2014;81 Suppl 1:1–122.CrossRef

13.

Dietlein M, Dressler J, Eschner W, Deutsche Gesellschaft für Nuklearmedizin, Deutsche Gesellschaft für Medizinische Physik, et al. Procedure guideline for iodine-131 whole-body scintigraphy for differentiated thyroid cancer (version 3). Nuklearmedizin. 2007;46:206–12.PubMed

14.

Gonzalez Carvalho JM, Görlich D, Schober O, Wenning C, Riemann B, Verburg FA, et al. Evaluation of (131)I scintigraphy and stimulated thyroglobulin levels in the follow-up of patients with DTC: a retrospective analysis of 1420 patients. Eur J Nucl Med Mol Imaging. 2016. doi:10.1007/s00259-016-3581-4.PubMed

15.

Xing M, Alzahrani AS, Carson KA, et al. Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer. JAMA. 2013;10(309):1493–501.CrossRef

16.

Liu R, Bishop J, Zhu G, Zhang T, Ladenson PW, Xing M. Mortality risk stratification by combining BRAF V600E and TERT promoter mutations in papillary thyroid cancer: genetic duet of BRAF and TERT Promoter Mutations in Thyroid Cancer Mortality. JAMA Oncol. 2016. doi:10.1001/jamaoncol.2016.3288.PubMedCentral

17.

Kandil E, Noureldine SI, Abbas A, Tufano RP. The impact of surgical volume on patient outcomes following thyroid surgery. Surgery. 2013;154:1346–52.CrossRefPubMed

18.

Luster M, Clarke SE, Dietlein M, Lassmann M, Lind P, Oyen WJ, et al. Guidelines for radioiodine therapy of differentiated thyroid cancer. Eur J Nucl Med Mol Imaging. 2008;35:1941–59.CrossRefPubMed

19.

Ruhlmann M, Binse I, Bockisch A, Rosenbaum-Krumme SJ. Initial [18F]FDG PET/CT in high-risk DTC patients. A three-year follow-up. Nuklearmedizin. 2016;55:99–103.CrossRefPubMed

Title: Less is more: reconsidering the need for regular use of diagnostic whole body radioiodine scintigraphy in the follow-up of differentiated thyroid cancer
Authors: Christian Pirich
Gregor Schweighofer-Zwink
Publication date: 01-05-2017
Publisher: Springer Berlin Heidelberg
Published in: European Journal of Nuclear Medicine and Molecular Imaging / Issue 5/2017
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-017-3632-5

At a glance: The STEP trials

Springer Medicine

Less is more: reconsidering the need for regular use of diagnostic whole body radioiodine scintigraphy in the follow-up of differentiated thyroid cancer

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 5/2017

Textural features of 18F-fluorodeoxyglucose positron emission tomography scanning in diagnosing aortic prosthetic graft infection

Andrea Ciarmiello and Luigi Mansi (eds): PET/CT and PET/MRI in neurology. SWOT analysis applied to hybrid imaging

From inflammation to calcification in atherosclerosis

Ken Herrmann, Omgo E. Neiweg and Stephen P. Povoski (eds): Radioguided Surgery. Current Applications and Innovative Directions in Clinical Practice

Inter-rater variability of visual interpretation and comparison with quantitative evaluation of 11C-PiB PET amyloid images of the Japanese Alzheimer’s Disease Neuroimaging Initiative (J-ADNI) multicenter study

68Ga-Pentixafor PET/CT demonstrating higher CXCR4 density in small cell lung carcinoma than in non-small cell variant